May 31, 2017 Innovative Research's Single Donor Human Complement Serum was recently used in the following study:
Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis opticaLukmanee Tradtrantip, Xiaoming Yao, Tao Su, Alex J. Smith, Alan S. Verkman - Acta Neuropathologica, 2017 ... Complement dependent cytotoxicity Specified concentrations of AQP4-IgG (or control human IgG, Thermo Fisher Scientific, Rockford, IL) and human complement (Innovative Research, Novi, MI) were added in Hank's buffer, and cells were incubated at 37 Â°C for specified times. ...
Share this post
Normal Single Donor Human Plasma from Innovative Research was recently used in the foll...Read the Article
Short communication: Effects of meloxicam administration on protein metabolism and growth performance in transported Jersey calves
Bovine Haptoglobin ELISA Kit from Innovative Research was recently used in the followin...Read the Article
Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies
Human Serum from Innovative Research was recently used in the following study: Enha...Read the Article